Director, Global Clinical Supply, Due Diligence and Integration (Hybrid)
MerckJob Description Global Clinical Supply (GCS) organization within our Company's Research Laboratories and is accountable for managing the 'end-to-end' integrated clinical supply chain across our Research & Development Division enabling the execution of all our clinical trials with a #No patient left behind mindset. GCS supports more than 300 Phase I-IV clinical trials run inhouse, 400+ outsourced or run by partners as well as our Company's ISS clinical trials (300+). GCS is accountable for the planning, sourcing, labeling, packaging and delivery of clinical supplies to clinical sites across more than 60+countries, all in accordance with US and WW regulations, company policies and Standard operating procedures. The Global Clinical Supplies (GCS) Due Diligence and Integration (DDI) Lead plays a critical leadership role in unlocking the value of breakthrough science and advancing our Company's growing portfolio. The Director supports front-end diligence efforts and spearheads the end-to-end clinical supply chain integration of Business Development & Licensing (BD&L) assets. Leading from pre-deal supply chain evaluation through complete business hand-off, the Director operates at the cross-functional intersection of the Integration Management Office (IMO), clinical trial operations, CMC development, regulatory affairs, quality, procurement, and finance. The incumbent provides strategic leadership and end-to-end accountability for the supply chain integration team, ensuring newly acquired assets, strategic alliances, and collaborative portfolios are seamlessly transitioned into standard operations without disruption to business continuity and clinical trial timelines. The Director brings strong business acumen, emotional intelligence, enterprise leadership, and change management capability to shape asset transition strategies, during complex integration lifecycles. Key responsibilities include representing GCS on due diligence teams to assess clinical supply chain risk posture, demand-supply, and resource requirements; defining and advancing compliant clinical supply chain integration strategies; and driving post-deal operational deliverables, timelines, and risk mitigation while ensuring business continuity of ongoing studies. This role leads through influence across GCS functions and key stakeholders to ensure effective decision-making, transparency, accountability, and value realization across the integration lifecycle. The Director will also drive continuous improvement, process standardization, and the maturation of DDI integration playbooks and fostering stronger connectivity and execution across the E2E clinical supply chain in alignment with strategic business needs. Key Responsibilities include but not limited to: The Director, Global Clinical Supply Due Diligence and Integration, leads due diligence and clinical supply chain integration of BD&L assets, ensuring a seamless, compliant, and cost-effective transition into our Company's clinical supply chain. Represent GCS on Due Diligence teams - synthesize cross-functional inputs (clinical, CMC etc) to define clinical supply chain risk posture, project clinical supply demand and estimate resource/budget requirements. Assess impact of BD&L transaction structures (e.g., acquisitions, ring-fence, collaborations etc) to clinical supply chain operational risks, connecting cause and effect, utilizing organizational expertise to implement and influence risk mitigation plans. Partner across the E2E supply chain to drive integration strategy and transition into our company's stable operations (business as usual), while ensuring business continuity of ongoing clinical studies. Facilitate structured knowledge management from legacy partners to GCS. Support strategic talent retention and integration of legacy colleagues into our Company's network. Proactively manage stakeholders and escalate risks to GCS and cross-functional leadership and governance. Lead GCS leadership reviews for assi…